“Novartis Halts Distribution of Zantac Drug Amid Probe into Impurities”, CBC

We can’t imagine that your reaction was any different than ours. Widely used Zantac, marketed as an over-the-counter heartburn medication, is under a distribution halt in Canada. The September 18, 2019 article by Thomson Reuters for CBC, “Novartis Halts Distribution of Zantac Drug Amid Probe into Impurities” (3 minute read) outlines the reason for the halt. Ranitidine, the active ingredient in Zantac, has been found to be contaminated with NDMA (N-nitrosodimethylamine), a probable human carcinogen. 

READ THE FULL POSTING